Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119103334 | 11910333 | 4 | F | 2015 | 20160713 | 20160112 | 20160722 | EXP | US-GLAXOSMITHKLINE-US2016001797 | GLAXOSMITHKLINE | 0.00 | M | Y | 0.00000 | 20160722 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119103334 | 11910333 | 1 | PS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | U | 5ZP1526 | 21077 | 1 | DF | INHALATION POWDER | BID | ||||
119103334 | 11910333 | 2 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | U | 6ZP3966 | 21077 | 1 | DF | INHALATION POWDER | BID | ||||
119103334 | 11910333 | 3 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 2 PUFF(S), QD | U | SC7R | 0 | 2 | DF | QD | |||||
119103334 | 11910333 | 4 | C | ASPIRIN. | ASPIRIN | 1 | UNK | U | 0 | ||||||||||
119103334 | 11910333 | 5 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | UNK | U | 0 | ||||||||||
119103334 | 11910333 | 6 | C | SEROQUEL | QUETIAPINE FUMARATE | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
119103334 | 11910333 | 1 | Lung disorder |
119103334 | 11910333 | 2 | Chronic obstructive pulmonary disease |
119103334 | 11910333 | 3 | Chronic obstructive pulmonary disease |
119103334 | 11910333 | 4 | Product used for unknown indication |
119103334 | 11910333 | 5 | Product used for unknown indication |
119103334 | 11910333 | 6 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
119103334 | 11910333 | Cough | |
119103334 | 11910333 | Drug ineffective | |
119103334 | 11910333 | Product quality issue | |
119103334 | 11910333 | Respiratory rate decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
119103334 | 11910333 | 1 | 201510 | 0 |